AmpliChip CYP450 Test

Similar topics in Freebase

• 

  Oncotype DX

  Oncotype DX, created by Genomic Health, is a diagnostic test that quantifies the likelihood of disease recurrence in women with early-stage breast cancer and assesses the likely benefit from certain types of chemotherapy. Oncotype DX was developed for women with early-stage invasive breast cancer...
• 

  Anakinra

  Anakinra (Kineret) is a drug used to treat rheumatoid arthritis. Anakinra is an interleukin-1 (IL-1) receptor antagonist. Anakinra blocks the biologic activity of naturally occurring IL-1, including inflammation and cartilage degradation associated with rheumatoid arthritis, by competitively...
• 

  Imatinib

  Imatinib is a drug used to treat certain types of cancer. It is currently marketed by Novartis as Gleevec (USA) or Glivec (Europe/Australia) as its mesylate salt, imatinib mesilate (INN). It was originally coded during development as CGP57148B or STI-571 (these terms are used in early preclinical...

• Irinotecan

  Irinotecan (Camptosar, Pfizer; Campto, Yakult Honsha) is a drug used for the treatment of cancer. Irinotecan is a topoisomerase 1 inhibitor, which prevents DNA from unwinding. Chemically, it is a semisynthetic analogue of the natural alkaloid camptothecin. Its main use is in colon cancer,...

• Estrasorb

• MMD BCR-ABL Quantitation

• MMD BRC-ABL Mutations

• PEGASYS

  Pegylated interferon alfa-2a (40 kDa; commercial name Pegasys) is an antiviral drug discovered at the pharmaceutical company F. Hoffmann-La Roche; it has a dual mode of action - both antiviral and on the immune system. The additon of polyethylene glycol to the interferon, through a process known as...

• Daclizumab

  Daclizumab (trade name Zenapax) was a therapeutic humanized monoclonal antibody to the alpha subunit of the IL-2 receptor of T cells. It was used to prevent rejection in organ transplantation, especially in kidney transplants. In April 2008, its manufacturer submitted an application to have its...

• Pegfilgrastim

  Pegfilgrastim is a immunostimulator which functions as a PEGylated granulocyte colony-stimulating factor. Amgen manufactures pegfilgrastim under the brand name Neulasta.